| Description | The STAG2 gene encodes two alternative isoforms: - A: Q8N3U4-1, 1231 aa, 141.3 KDa - B: Q8N3U4-2, 1268 aa, 145.7 KDa |
| |  |
| |
| | Figure 2. Domain structure of STAG2 and amino acid sequence. |
| |
| Expression | STAG2 mRNA is expressed in cells from most tissues. Peak expression occurs in T-cell and early erythroid compartments, and in the uterus. Lowest expression is found in brain, heart, liver, lung and testis. STAG2 is also overexpressed in T-/B-cell acute lymphoblastic leukemia (ALL) and in other hematopoietic neoplasias, followed by small cell lung cancer, neuroblastoma and medulloblastoma. It has been reported that the expression of STAG2 protein is lost in some cancer types such as glioblastoma, Ewing's sarcoma, and melanoma (Solomon et al., 2011), colorectal carcinomas, gastric carcinomas and prostate carcinomas (Kim et al., 2012). |
| Localisation | Nucleus albeit reportedly with transmembrane potential. |
| Function | STAG2 forms the cohesin complex together with SMC1, SMC3, and SCC1. The cohesin complex is a ring-like structure and is required for cohesion of sister chromatids after DNA replication. The complex is cleaved at the metaphase-anaphase transition and dissociates from chromatin for separation of sister chromatids (Xiao et al., 2011). While STAG2 mediates centromere cohesion, that of telomeres is mediated by the homologous STAG1 (Canudas et al., 2009; Remeseiro et al., 2012). Cohesin also plays a major part in the organization of interphase chromatin, including the orchestration of gene expression in relation to cell cycle where STAG2 also plays a key role along with the universal transcriptional repressor CCCTC-binding factor (CTCF). CTCF-cohesin interactions require contact between STAG2 and C-terminal CTCF which facilitate recruitment of other cohesion complex proteins and formation of the cohesion ring. This interaction is also needed for CTCF to function as a transcriptional insulator. |
| Homology | Two paralogs are known: STAG1 and STAG3 which can replace STAG2 in the cohesion complex. |
| |  |
| |
| Note | |
| | |
| Entity | Myeloid neoplasms |
| Note | Mutation and deletion of the STAG2 gene was identified in 5.8% (13/224) of MDS, 10.2% (9/88) of CMML, 6.4% (10/157) of AML, 3.1% (2/64) of CML, and 1.3% (1/77) of MPN: the STAG2 alterations were mostly exclusive with alterations involving other components of cohesin complex (SMC1, SMC3, and RAD21) and were significantly associated with mutations in TET2, ASXL1, and EZH2 (Kon et al., 2013). |
| | |
| | |
| Entity | t(X;11)(q25;p13) |
| Disease | T-ALL: only two T-ALL cell lines described so far. |
| Cytogenetics | t(X;11)(q25;p13) in MOLT-14 cells and t(X;1;11)(q25;p13;p13) in PER-117 cells. The rearrangement is fully cryptic (see below). |
| |  |
| |
| Figure 4. Cytogenetic analysis of t(X;11) effecting juxtaposition of STAG2 and LMO2. Image shows FISH analysis of t(X;11)(q25;p13) in a T-ALL cell line (DSM ACC 437). Note that this translocation is cryptic in G-banding (Fig. A). FISH using BAC and fosmid clones (Fig. B, C) places breakpoints in MOLT-14 and another T-ALL cell line PER-117, both inside the first (regulatory) intron of STAG2. In both cell lines expression of STAG2 is lost, attributable to divestment of this region which includes a deeply conserved cluster of regulatory motifs, including transcription factor binding sites and DNaseI sensitive sites. Upregulation of LMO2 in both cell lines occurred, concomitant with acquisition of the upstream STAG2 region. Fig. D: Genomic map of Xq25 showing breakpoints in regulatory region in relation to clones used for FISH. Figure redrawn and updated from Chen et al. (2011). |
| |
| Oncogenesis | t(X;11)(q25;p13) results in simultaneous upregulation of LMO2 and silencing of STAG2 by juxtaposition of the far upstream region of LMO2 with the first regulatory intron of STAG2 (Chen et al., 2011). |
| | |
| Differential regulation of telomere and centromere cohesion by the Scc3 homologues SA1 and SA2, respectively, in human cells. |
| Canudas S, Smith S. |
| J Cell Biol. 2009 Oct 19;187(2):165-73. doi: 10.1083/jcb.200903096. Epub 2009 Oct 12. |
| PMID 19822671 |
| |
| Novel non-TCR chromosome translocations t(3;11)(q25;p13) and t(X;11)(q25;p13) activating LMO2 by juxtaposition with MBNL1 and STAG2. |
| Chen S, Nagel S, Schneider B, Kaufmann M, Meyer C, Zaborski M, Kees UR, Drexler HG, MacLeod RA. |
| Leukemia. 2011 Oct;25(10):1632-5. doi: 10.1038/leu.2011.119. Epub 2011 Jun 7. |
| PMID 21647158 |
| |
| Somatic mutation of STAG2, an aneuploidy-related gene, is rare in acute leukemias. |
| Chung NG, Kim MS, Yoo NJ, Lee SH. |
| Leuk Lymphoma. 2012 Jun;53(6):1234-5. doi: 10.3109/10428194.2011.645819. Epub 2012 Jan 3. |
| PMID 22132872 |
| |
| Condensin and cohesin: more than chromosome compactor and glue. |
| Hagstrom KA, Meyer BJ. |
| Nat Rev Genet. 2003 Jul;4(7):520-34. (REVIEW) |
| PMID 12838344 |
| |
| Mutational and expressional analyses of STAG2 gene in solid cancers. |
| Kim MS, Kim SS, Je EM, Yoo NJ, Lee SH. |
| Neoplasma. 2012;59(5):524-9. doi: 10.4149/neo_2012_067. |
| PMID 22668012 |
| |
| Cancer. Aneuploidy drives a mutator phenotype in cancer. |
| Kolodner RD, Cleveland DW, Putnam CD. |
| Science. 2011 Aug 19;333(6045):942-3. doi: 10.1126/science.1211154. |
| PMID 21852477 |
| |
| Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms. |
| Kon A, Shih LY, Minamino M, Sanada M, Shiraishi Y, Nagata Y, Yoshida K, Okuno Y, Bando M, Nakato R, Ishikawa S, Sato-Otsubo A, Nagae G, Nishimoto A, Haferlach C, Nowak D, Sato Y, Alpermann T, Nagasaki M, Shimamura T, Tanaka H, Chiba K, Yamamoto R, Yamaguchi T, Otsu M, Obara N, Sakata-Yanagimoto M, Nakamaki T, Ishiyama K, Nolte F, Hofmann WK, Miyawaki S, Chiba S, Mori H, Nakauchi H, Koeffler HP, Aburatani H, Haferlach T, Shirahige K, Miyano S, Ogawa S. |
| Nat Genet. 2013 Oct;45(10):1232-7. doi: 10.1038/ng.2731. Epub 2013 Aug 18. |
| PMID 23955599 |
| |
| Cohesin, a chromatin engagement ring. |
| Remeseiro S, Losada A. |
| Curr Opin Cell Biol. 2013 Feb;25(1):63-71. doi: 10.1016/j.ceb.2012.10.013. Epub 2012 Dec 6. (REVIEW) |
| PMID 23219370 |
| |
| Alteration of cohesin genes in myeloid diseases. |
| Rocquain J, Gelsi-Boyer V, Adelaide J, Murati A, Carbuccia N, Vey N, Birnbaum D, Mozziconacci MJ, Chaffanet M. |
| Am J Hematol. 2010 Sep;85(9):717-9. doi: 10.1002/ajh.21798. |
| PMID 20687102 |
| |
| Mutational inactivation of STAG2 causes aneuploidy in human cancer. |
| Solomon DA, Kim T, Diaz-Martinez LA, Fair J, Elkahloun AG, Harris BT, Toretsky JA, Rosenberg SA, Shukla N, Ladanyi M, Samuels Y, James CD, Yu H, Kim JS, Waldman T. |
| Science. 2011 Aug 19;333(6045):1039-43. doi: 10.1126/science.1203619. |
| PMID 21852505 |
| |
| Specific sites in the C terminus of CTCF interact with the SA2 subunit of the cohesin complex and are required for cohesin-dependent insulation activity. |
| Xiao T, Wallace J, Felsenfeld G. |
| Mol Cell Biol. 2011 Jun;31(11):2174-83. doi: 10.1128/MCB.05093-11. Epub 2011 Mar 28. |
| PMID 21444719 |
| |